Health Care/Hospital
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER
HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Today, Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody), the first-inclass novel immuno-oncology drug independently developed by the Company, combined with concurrent chemoradiotherapy obtained approval from the Center for Dru...
2022-01-04 10:00
2190
TCI's Golden Formula Has Won the Best Plant-Based Functional Product in the World Plant-Based Awards 2021
TAIPEI, Jan. 3, 2022 /PRNewswire/ -- In recent years, there has been a global trend of plant-based health care, which is known as vegetarian food in Taiwan. In the World Plant-Based Awards, jointly organized by FoodBev Media and Plant Based World Expo & Conference, TCI's Golden Formula won the be...
2022-01-04 09:00
1807
Asieris Announces the World's First Patient Dose Administered in Combination of Asieris'APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients
SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors, today announced that the world's first patient dose has been administered in U.S. for its oral APL-1202 in combination ...
2022-01-04 08:06
1563
Seoul National University will participate in CES 2022 with 10 prospective unicorns
LAS VEGAS, Jan. 3, 2022 /PRNewswire/ -- Seoul National University (President Se-Jung OH) will dispatch the "SNU Exhibition Group" to the world's largest IT and home appliance exhibition (CES) 2022 to be held in Las Vegas for four days fromJanuary 5th of the new year, and showcase representative s...
2022-01-03 22:00
1826
EVOSONICS will launch 12 products including Sleep tech Sound pillows at CES 2022
WONJU, South Korea, Jan. 3, 2022 /PRNewswire/ -- EVOSONICS (CEO Jason Choi), a sound vibration-based healthcare company, announced on the 30th that it will submitsleep tech devices, rehabilitation devices and obesity management devices through CES2022 inLas Vegas, USA, from January 5, 2022. ...
2022-01-03 21:00
1775
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
NEWARK, Del. and NANJING, China, Jan. 3, 2022 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a global clinical stage biotechnology company, today announced the appointment of Dr.Anthony Yeh to the position of Chief Strategy Officer and Head ofChina business development (BD), where he will lead corpor...
2022-01-03 18:00
1751
Pulnovo Medical Announced Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH) Meet The Efficacy Primary Endpoint
SHANGHAI, Jan. 1, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in treatment for cardiopulmonary disease, today announced the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study, being the first global completed pulmonary hyperten...
2022-01-01 20:30
2565
TODOC to Introduce High-Performance and Low-Cost Artificial Cochlear Implant 'SULLIVAN' at CES 2022
SEOUL, South Korea, Dec. 31, 2021 /PRNewswire/ -- TODOC (CEO Min Gyu-sik) will introduce their artificial cochlear implant 'SULLIVAN' at the "CES 2022" which will be held inLas Vegas on January 5, 2022 (local time), after it was selected in the 'Top 10 Korean Products of CES 2022.' Organized by ...
2022-01-01 01:00
3539
I-Mab Announces Upcoming Participation at January Conferences
SHANGHAI and GAITHERSBURG, MD., Dec. 31, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences inJanuar...
2021-12-31 21:00
2703
GBB Closed the A Round Financing with Newly Joined FutureX Capital
HONG KONG, Dec. 31, 2021 /PRNewswire/ -- Great Bay Bio (GBB), an AI-enabled
biotechnology company, announces the participation of FutureX Capital in its
Series A round fundraising.
2021-12-31 20:44
2865
Zepp Health Provides Updates to Guidance and Share Repurchases
BEIJING, Dec. 31, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) announced today an update to its guidance for the fourth quarter 2021, as well as an update to the progress of its share repurchase program. Due to greater than anticipated effects of Covid, including a more persistent worldw...
2021-12-31 20:00
5077
Landmark international innovation and entrepreneurship competition concludes in China's Chongqing with top prize worth 100 mln yuan
CHONGQING, China, Dec. 31, 2021 /PRNewswire/ -- Chongqing Liangjiang Collaborative Innovation Zone Mingyue Lake International Innovation and Entrepreneurship Competition concluded Thursday in Chongqing Liangjiang New Area. Contestants across the country leveraged their ideas and proposals to win ...
2021-12-31 19:15
2303
GenFleet Therapeutics Raises $75 Million in Series C Financing Led by Huagai Capital, to Advance Innovative Pipeline Highlighting Cutting-edge Therapies
SHANGHAI, Dec. 31, 2021 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company with a focus in cutting-edge therapies in oncology and immunology, today announced the completion of$75 million (~500 million RMB) series C financing. This round of financing is led by Huagai ...
2021-12-31 19:00
1922
China Medical System (867.HK)'s Latest MSCI ESG Rating Unchanged at AA, Leading the Industry Globally
HONG KONG, Dec. 30, 2021 /PRNewswire/ -- Recently, Morgan Stanley Capital International (MSCI), the world's largest index provider, has updated the Environmental, Social and Governance (ESG) rating of China Medical System Holdings Limited ("CMS" or the "Company").CMS's latest rating remains uncha...
2021-12-30 20:00
2217
Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology
SUZHOU, China, Dec. 30, 2021 /PRNewswire/ -- On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement ("TSMVR") technology was successfully carried out inAsia. The implantation of Peijia's Highlife TSMVR system was performed by ProfessorMao Chen and his te...
2021-12-30 19:18
2290
Dada Group and Kimberly-Clark China Strengthen Partnership to Create New Growth of Healthcare Brands in On-demand Retail
SHANGHAI, Dec. 29, 2021 /PRNewswire/ -- Kimberly-Clark (China) Co., Ltd., the global leader in the personal care and hygiene industry, and Dada Group (Nasdaq: DADA), China's leading local on-demand delivery and retail platform, announced a plan to strengthen their strategic partnership. Philip KU...
2021-12-30 10:57
2116
iMEDISYNC UNVEILS WORLD'S FIRST INTEGRATED WIRELESS BRAIN EEG at CES 2022
SEOUL, South Korea, Dec. 29, 2021 /PRNewswire/ -- iMediSync, a leading AI-driven early detection and therapeutic platform for optimal brain health from Seoul, South Korea announced today that the company will showcase its comprehensive EEG solution (hardware + software + remote telehealth solution...
2021-12-30 00:00
2561
China Jo-Jo Drugstores Receives 2021 China ESG Golden Awards- Sustainability Award from Sina Finance
HANGZHOU, China, Dec. 29, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that the ...
2021-12-29 21:30
4170
SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical
SUZHOU, China, Dec. 29, 2021 /PRNewswire/ -- SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical. With this win-win collaboration, SyMap has full rights to utilize all assets of Pythagoras, including their Renal Nerve Mapping System (ConfidenHT™, CE Mark Appro...
2021-12-29 20:30
1929
EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH
* Establishment of Joint Venture Company named SanPlena in the US * Drug-device combination of EOFlow's smart wearable drug delivery platform and novel peptide derivatives developed by a team led by Prof. SirStephen Bloom , world-renowned researcher in the field of obesity and metabolism at Imp...
2021-12-28 22:00
1648
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
7890
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
6253
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
6063
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
5834
